Newly discovered gene regulator could precisely target sickle cell disease
A research team from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and other institutions has discovered a new genetic target for potential therapy of sickle cell disease (SCD). The target, called an enhancer, controls a molecular switch in red blood cells called BCL11A that, in turn, regulates haemoglobin production. The researchers were led by Daniel […]
